Cameco Corporation Shares Climb 1.8% Following Analyst Ratings

Cameco Corporation (NYSE: CCJ) experienced a 1.8% increase in its stock price during trading on Friday, reaching a high of $123.32 before closing at $121.16. Approximately 4,724,098 shares changed hands, reflecting a slight decrease from the average volume of 4,746,609 shares. The stock had previously closed at $119.03.

Analyst Ratings Influence Market Performance

Several research firms have recently provided insights that significantly impact Cameco’s stock performance. On February 4, 2024, the Goldman Sachs Group reaffirmed a “buy” rating with a target price set at $131.00. Conversely, Wall Street Zen downgraded Cameco from a “buy” to a “hold” rating on November 8, 2023. National Bank Financial also maintained an “outperform” rating on the stock, while UBS Group initiated coverage with a “neutral” rating and a target price of $140.00. Most notably, the Royal Bank of Canada raised its target price for Cameco from $150.00 to $160.00, maintaining an “outperform” rating.

Overall, investment analysts have mixed reviews for Cameco, with one analyst recommending a Strong Buy, twelve assigning a Buy rating, and three issuing a Hold rating. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” with a target price of $143.03.

Company Performance and Financial Metrics

Cameco’s financial metrics indicate a robust position within the market. The company reports a current ratio of 2.47, a quick ratio of 1.85, and a low debt-to-equity ratio of 0.14. With a market capitalization of $52.77 billion and a price-to-earnings ratio of 124.91, Cameco presents a stable investment, characterized by a beta of 0.99. The company’s 50-day moving average stands at $108.78 while the 200-day average is $93.40.

In its latest quarterly earnings report, released on February 13, 2024, Cameco posted earnings of $0.36 per share, surpassing the consensus estimate of $0.29 by $0.07. The firm achieved a net margin of 17.00% and a return on equity of 9.35%. Revenue for the quarter was $874.57 million, exceeding analyst expectations of $782.13 million and reflecting a year-over-year increase of 1.5%.

Investor sentiment surrounding Cameco remains generally positive, with analysts predicting an earnings per share (EPS) of $1.27 for the current fiscal year.

Institutional Investor Activity

Recent movements among institutional investors indicate growing interest in Cameco. Financial Consulate Inc. acquired a new stake valued at approximately $25,000 in the third quarter of 2023. Nisa Investment Advisors LLC and Founders Capital Management also bought new positions worth around $25,000 and $27,000, respectively, during the fourth quarter. Strategic Advocates LLC and Mcguire Capital Advisors Inc. similarly invested approximately $28,000 each in new stakes.

Currently, institutional investors hold a significant 70.21% of Cameco’s stock, highlighting the company’s appeal to larger investment entities.

Cameco Corporation, headquartered in Saskatoon, Saskatchewan, Canada, is a leading producer of uranium and a crucial supplier to the global nuclear power sector. The company specializes in the exploration, mining, milling, and sale of uranium concentrate, commonly known as yellowcake, which is vital for nuclear reactors. With a focus on operations in Canada and the United States, Cameco also engages in services supporting the front end of the nuclear fuel cycle, including the processing and marketing of uranium to utilities through long-term and spot contracts.